Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Effect on Gut Microbiota in Newly Diagnosed T2DM
NCT04426422Phase 4Completed
- Sponsor
- Shenzhen People's Hospital
- Start
- Mar 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Shenzhen People's Hospital. Started Mar 2017; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04426422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04426422.